Marinomed s Australian Carragelose distribution network strengthened dgap.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dgap.de Daily Mail and Mail on Sunday newspapers.
DGAP-News: AFFiRiS AG / Key word(s): Study results AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9 to treat hypercholesterolemia published by the European Journal of Clinical Pharmacology 27.05.2021 / 11:00 The issuer is solely responsible for the content of this announcem.
DGAP-News: AFFiRiS AG / Key word(s): Study results AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9 to treat hypercholesterolemia published by the European Journal of
(0)
DGAP-News: AFFiRiS AG / Key word(s): Conference/Study
AFFiRiS AG: Positive preclinical in vivo results with AFFiRiS antibody mAB C6-17 to treat Huntington s disease to be presented at the 16th Annual Huntington s Disease Therapeutics Conference
27.04.2021 / 09:00
Positive preclinical
in vivo results with AFFiRiS antibody mAB C6-17 to treat Huntington s disease to be presented at the 16
th Annual Huntington s Disease Therapeutics Conference
- Monoclonal antibody C6-17 designed to target mutant huntingtin protein (mtHTT) and to reduce spread of Huntington s disease pathology
- Human mtHTT transgenic mice treated with mAB C6-17 showed significantly reduced mtHTT levels in peripheral organs and central nervous system and displayed improved motor performance